Literature DB >> 8154867

Single muscle fiber analysis of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).

M Tokunaga1, S Mita, T Murakami, T Kumamoto, M Uchino, I Nonaka, M Ando.   

Abstract

We examined muscle sections from 3 patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), using single-fiber polymerase chain reaction, histochemistry, and in situ hybridization. Most type 1 ragged-red fibers showed positive cytochrome c oxidase activity at the subsarcolemmal region, while type 2 ragged-red fibers had little cytochrome c oxidase activity. However, there was no difference in the amount of total (mutant and wild-type) mitochondrial DNAs (mtDNAs) and the proportion of mutant mtDNA between type 1 and type 2 ragged-red fibers. These observations suggest that mitochondrial proliferation and nuclear factors affect muscle pathology, including cytochrome c oxidase activity, in MELAS. Total mtDNAs were greatly increased in ragged-red fibers (about 5-17 times over those in non-ragged-red fibers). The proportion of mutant mtDNA was significantly higher in ragged-red fibers (88.1 +/- 5.5%) than in non-ragged-red fibers (63.2 +/- 21.6%). Thus, the amount of wild-type mtDNA as well as mutant mtDNA was increased in ragged-red fibers in MELAS, failing to support the contention of a replicative advantage of mutant mtDNA. The proportion of mutant mtDNA was significantly higher in the strongly succinate dehydrogenase-reactive blood vessels (83.2 +/- 4.2%) than in non-succinate dehydrogenase-reactive blood vessels (38.8 +/- 16.2%). It seems likely that systemic vascular abnormalities involving cerebral vessels lead to the evolution of stroke-like episodes in MELAS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8154867     DOI: 10.1002/ana.410350407

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

1.  Relaxed replication of mtDNA: A model with implications for the expression of disease.

Authors:  P F Chinnery; D C Samuels
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

2.  Normal levels of wild-type mitochondrial DNA maintain cytochrome c oxidase activity for two pathogenic mitochondrial DNA mutations but not for m.3243A-->G.

Authors:  Steve E Durham; David C Samuels; Lynsey M Cree; Patrick F Chinnery
Journal:  Am J Hum Genet       Date:  2007-05-23       Impact factor: 11.025

3.  Single-cell analysis of mitochondrial DNA in patients and a carrier of the tRNA(Leu)(UUR) gene mutation.

Authors:  S Saitoh; M Y Momoi; T Yamagata; H Nakauchi; K Nihei; M Fujii
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

4.  Mitochondrial gene mutations and human diseases: a prolegomenon.

Authors:  N Howell
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

5.  Segregation of mtDNA throughout human embryofetal development: m.3243A>G as a model system.

Authors:  Sophie Monnot; Nadine Gigarel; David C Samuels; Philippe Burlet; Laetitia Hesters; Nelly Frydman; René Frydman; Violaine Kerbrat; Benoit Funalot; Jelena Martinovic; Alexandra Benachi; Josué Feingold; Arnold Munnich; Jean-Paul Bonnefont; Julie Steffann
Journal:  Hum Mutat       Date:  2011-01       Impact factor: 4.878

6.  Context-Dependent Role of Mitochondrial Fusion-Fission in Clonal Expansion of mtDNA Mutations.

Authors:  Zhi Yang Tam; Jan Gruber; Barry Halliwell; Rudiyanto Gunawan
Journal:  PLoS Comput Biol       Date:  2015-05-21       Impact factor: 4.475

7.  Importance of Distinguishing Between Mitochondrial Encephalomyopathy With Elderly Onset of Stroke-Like Episodes and Cerebral Infarction.

Authors:  Syuichi Tetsuka; Asako Tagawa; Tomoko Ogawa; Mieko Otsuka; Ritsuo Hashimoto; Hiroyuki Kato
Journal:  J Clin Med Res       Date:  2017-07-27

8.  Energetic costs of cellular and therapeutic control of stochastic mitochondrial DNA populations.

Authors:  Hanne Hoitzing; Payam A Gammage; Lindsey Van Haute; Michal Minczuk; Iain G Johnston; Nick S Jones
Journal:  PLoS Comput Biol       Date:  2019-06-26       Impact factor: 4.475

Review 9.  The molecular pathology of pathogenic mitochondrial tRNA variants.

Authors:  Uwe Richter; Robert McFarland; Robert W Taylor; Sarah J Pickett
Journal:  FEBS Lett       Date:  2021-02-12       Impact factor: 3.864

Review 10.  Mitochondrial DNA disorders: from pathogenic variants to preventing transmission.

Authors:  Tiago M Bernardino Gomes; Yi Shiau Ng; Sarah J Pickett; Doug M Turnbull; Amy E Vincent
Journal:  Hum Mol Genet       Date:  2021-10-01       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.